Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $33.69, moving +0.78% from the previous trading session.

Since VKTX is devoid of marketed drugs, investors will focus on pipeline updates when it reports Q4 results next week.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Hedge fund founder George Weiss filed a defamation suit in New York against Jefferies Financial (JEF), alleging the bank engaged in a “smear ...

Retail investors poured money into Nvidia shares as the stock saw its largest single-day drop since March 2020. ASML stock rose nearly 6% premarket after the Dutch semiconductor equipment company ...

Petroleo Brasileiro S/A Ord-1.00% R$503.67B Petroleo Brasileiro S/A Pref-0.62% R$503.67B ...

Liberty Media Corp. Series C Liberty Formula One-0.89% $29.75B Liberty Media Corp. Series A Liberty Formula One-0.15% $29.75B ...